arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

GLOBUS MEDICAL INC

GMED
$81.12 ▲ +0.62 (+0.77%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
17 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Bullish
auto_awesome

Analytical Summary

GLOBUS MEDICAL INC shows strong fundamentals with top-quartile Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $11.0B
Dividend Yield
Revenue Growth 16.7%
Op. Margin 16.3%
ROIC 9.3%
FCF / Share $4.35
Trailing P/E 20.4x
Price / Book 2.4x
FCF Yield 5.4%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 6, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.94B
↑ +16.7%
Net Income Profit after all expenses
$537.87M
↑ +422.3%
Operating Margin Operating profit as % of sales
16.3%
↑ +147.8% 69th
FCF / Share Free cash flow per share
$4.35
↑ +45.8%
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
77
Returns
73
Cash Quality
69

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 61 quarters